abstract |
(57) Abstract: The present invention relates to a novel arginine salt of 3- [4- [2- (phenoxazin-10-yl) ethoxy] phenyl] -2-ethoxypropanoic acid having the formula (I). It relates to the type form / pseudopolymorph form. The present invention also relates to a pharmaceutical composition comprising the novel polymorphic forms or mixtures thereof and a pharmaceutically acceptable carrier. The novel polymorphic forms of the present invention are better than the new 3- [4- [2- (phenoxazin-10-yl) ethoxy] phenyl] -2-ethoxypropanoic acid as antidiabetic and lipid lowering agents. Active. |